Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia 9Leukemia, Lymphocytic, Chronic, B-Cell 8Myelodysplastic Syndromes 5Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Multiple Myeloma 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Anemia, Refractory, with Excess of Blasts 3Sarcoma 2Neuroblastoma 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Large Granular Lymphocytic 2Anemia, Refractory 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Salivary Gland Neoplasms 1Recurrence 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 17fludarabine phosphate 16Cyclophosphamide 14Cyclosporine 13Whole-Body Irradiation 11Mycophenolic Acid 11Etoposide 7Methotrexate 6Tacrolimus 5Filgrastim 5Antilymphocyte Serum 5Therapeutics 4Rituximab 4Radiotherapy 4Psychiatric Rehabilitation 4Prednisone 4Methylprednisolone 4Melphalan 4Busulfan 4Bortezomib 4Alemtuzumab 4Transplantation 3Thiotepa 3Epoetin Alfa 3Dasatinib 3Darbepoetin alfa 3Carboplatin 3thymoglobulin 2ruxolitinib 2nelarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Large Granular Lymphocytic × Thalidomide × Other hematologic neoplasm × Clear all
NCT06530576 2025-11-18

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
48 enrolled
Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT04453345 2020-07-01

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Institute of Hematology & Blood Diseases Hospital, China

Phase 2/3 Unknown
42 enrolled
Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡